{
    "organizations": [],
    "uuid": "8f4afde7237e81893a92c04d880f2dcdeb97e070",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-alder-announces-250-million-commit/brief-alder-announces-250-million-committed-equity-financing-idUSASB0C039",
    "ord_in_thread": 0,
    "title": "BRIEF-Alder Announces $250 Million Committed Equity Financing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Alder Biopharmaceuticals Inc:\n* ALDER ANNOUNCES $250 MILLION COMMITTED EQUITY FINANCING * ALDER BIOPHARMACEUTICALS INC - INVESTORS TO PURCHASE UP TO $250 MILLION OF NON-VOTING CLASS A PREFERRED STOCK DURING 3-YEAR TERM OF AGREEMENT\n* ALDER BIOPHARMACEUTICALS INC - TO USE NET PROCEEDS TO FUND PAYMENTS UNDER ALDERâ€˜S EUROPEAN PATENT SETTLEMENT\n* ALDER BIOPHARMACEUTICALS INC - TO ALSO USE PROCEEDS FOR EPTINEZUMAB INFUSION COMMERCIALIZATION-READINESS ACTIVITIES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-08T21:08:00.000+02:00",
    "crawled": "2018-01-09T17:18:53.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "alder",
        "biopharmaceuticals",
        "inc",
        "alder",
        "announces",
        "million",
        "committed",
        "equity",
        "financing",
        "alder",
        "biopharmaceuticals",
        "inc",
        "investor",
        "purchase",
        "million",
        "class",
        "preferred",
        "stock",
        "term",
        "agreement",
        "alder",
        "biopharmaceuticals",
        "inc",
        "use",
        "net",
        "proceeds",
        "fund",
        "payment",
        "alder",
        "european",
        "patent",
        "settlement",
        "alder",
        "biopharmaceuticals",
        "inc",
        "also",
        "use",
        "proceeds",
        "eptinezumab",
        "infusion",
        "activity",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}